About Shelley Chu
Shelley Chu is a director at Enlaza Therapeutics.
Shelley Chu first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Shelley Chu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shelley Chu works with at each company, as listed on that company's latest Form D.
Enlaza Therapeutics, Inc. · Form D, Sep 11, 2025
MM
Marcos Milla
Director
SS
Stephen Squinto
Director
TR
Tighe Reardon
Executive officer
JL
Jay Lichter
Director
SD
Sergio Duron
Chief Executive Officer and director
JT
James Topper
Director
SM
Sanford Madigan
Executive officer